Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Aliment Pharmacol Ther ; 23(1): 75-84, 2006 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-16393283

RESUMEN

BACKGROUND: Intravenous administration of a third-generation cephalosporin is optimal antibiotic treatment for spontaneous bacterial peritonitis. AIMS: To compare an intravenous-oral step-down schedule with ciprofloxacin (switch therapy) to intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis, and to evaluate the impact of terlipressin and albumin in the treatment of type 1 hepatorenal syndrome on mortality. METHODS: A total of 116 cirrhotic patients with spontaneous bacterial peritonitis, were randomly given switch therapy with ciprofloxacin (61 patients) or intravenous ceftazidime (55 patients). All patients who developed type 1 hepatorenal syndrome were treated with terlipressin (2-12 mg/day) and albumin (20-40 g/day). RESULTS: Resolution of infection was achieved in 46/55 patients treated with ceftazidime (84%) and in 49/61 patients treated with ciprofloxacin (80%, P = N.S.). An intravenous-oral step-down schedule was possible in 50/61 patients (82%) who received ciprofloxacin; 45/61 patients (74%) were discharged before the end of antibiotic treatment and completed it at home. The mean saving per patient due to the reduction of hospital stay in the ciprofloxacin group was 1150 . Type 1 hepatorenal syndrome was treated successfully in 12/19 patients (63%). As a consequence, the in-hospital mortality rate due to infection was 10%. CONCLUSIONS: Switch therapy with cephalosporin is more cost-effective than intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in cirrhotic patients who are not on prophylaxis with quinolones.


Asunto(s)
Antibacterianos/administración & dosificación , Ceftazidima/administración & dosificación , Ciprofloxacina/administración & dosificación , Síndrome Hepatorrenal/tratamiento farmacológico , Cirrosis Hepática/complicaciones , Peritonitis/tratamiento farmacológico , Administración Oral , Albúminas/uso terapéutico , Antihipertensivos/uso terapéutico , Femenino , Costos de la Atención en Salud , Síndrome Hepatorrenal/mortalidad , Humanos , Infusiones Intravenosas , Tiempo de Internación , Lipresina/análogos & derivados , Lipresina/uso terapéutico , Masculino , Persona de Mediana Edad , Peritonitis/economía , Terlipresina
2.
Can J Microbiol ; 47(7): 685-9, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11547891

RESUMEN

The effect of industrial carbon sources on phospholipid transfer protein production was investigated. Phospholipid fractions of different composition were prepared from various plant oils (i.e., soybean, rapeseed, and sunflower) according to the Lucas Meyer extraction and purification process. The effect of these fractions on phospholipid transfer protein activity of cell extracts from Aspergillus oryzae grown on medium containing these phospholipids as sole carbon source was studied. It was shown that phospholipid transfer activity was markedly increased by extracts containing a particular phospholipid composition. However, this stimulation depends mainly upon the phospholipid composition of the fraction used as fermentation substrate. Fractions enriched mainly in phosphatidylinositol (Epikuron 110), at the expense of phosphatidylcholine, were the most efficient sources for phospholipid transfer protein production by A. oryzae. Maximal phospholipid transfer activity, as well as biomass production, were increased 4.1- and 9.7-fold, respectively, when cultures were supplemented with Epikuron 110 prepared from sunflower lecithin, as compared to glucose-control cultures.


Asunto(s)
Aspergillus oryzae/crecimiento & desarrollo , Proteínas Portadoras/metabolismo , Proteínas de la Membrana/metabolismo , Proteínas de Transferencia de Fosfolípidos , Fosfolípidos/metabolismo , Aceites de Plantas/química , Aspergillus oryzae/metabolismo , Medios de Cultivo , Microbiología Industrial , Fosfolípidos/aislamiento & purificación
3.
Lett Appl Microbiol ; 32(4): 262-7, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11298938

RESUMEN

AIMS: The biotransformation of L-phenylalanine into benzaldehyde (bitter almond aroma) was studied in the strain Trametes suaveolens CBS 334.85. METHODS AND RESULTS: Cultures of this fungus were carried out in the absence or in the presence of HP20 resin, a highly selective adsorbent for aromatic compounds. For the identification of the main catabolic pathways of L-phenylalanine, a control medium (without L-phenylalanine) was supplemented with each of the aromatic compounds, previously detected in the culture broth, as precursors. Trametes suaveolens CBS 334.85 was shown to biosynthesize benzyl and p-hydroxybenzyl derivatives, particularly benzaldehyde, and large amounts of 3-phenyl-1-propanol, benzyl and p-hydroxybenzyl alcohols as the products of both cinnamate and phenylpyruvate pathways. CONCLUSION: The addition of HP20 resin, made it possible to direct the catabolism of L- phenylalanine to benzaldehyde, the desired target compound, and to trap it before its transformation into benzyl alcohol. In these conditions, benzaldehyde production was increased 21-fold, from 33 to 710 mg l-1 corresponding to a molar yield of 31%. SIGNIFICANCE AND IMPACT OF THE STUDY: These results showed the good potential of Trametes suaveolens as a biotechnological agent to synthesize natural benzaldehyde which is one of the most important aromatic aldehydes used in the flavour industry.


Asunto(s)
Benzaldehídos/metabolismo , Fenilalanina/metabolismo , Polyporales/metabolismo , Alcohol Bencilo , Biotecnología/métodos , Biotransformación/efectos de los fármacos , Aditivos Alimentarios , Polyporales/crecimiento & desarrollo , Resinas de Plantas/metabolismo
4.
Ann Thorac Surg ; 64(6): 1770-5, 1997 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9436570

RESUMEN

BACKGROUND: Although most preservation solutions as well as some cardioplegic solutions used for organ storage and transplantation are hypertonic, the effects of extracellular hypertonicity on endothelium are not well established. Aims of this study were to evaluate the response of cultured human saphenous vein endothelial cells to extracellular hypertonicity and to investigate the role of the amino acid glutamine in preventing endothelial damage in vitro. METHODS: Eight distinct strains of human saphenous vein endothelial cells were studied. Hypertonic (350 and 400 mosm/kg) media were obtained by supplementing culture medium with sucrose. Cell viability was assessed in the absence or the presence of glutamine through the determination of cell number and protein content of the cultures. Confocal microscopy of cells loaded with the fluorescent dye calcein was also performed. RESULTS: Exposure of human saphenous vein endothelial cells to hypertonic media without glutamine caused significant cell loss within 30 minutes. Cell loss progressed steadily during incubation and after 6 hours reached 50% at 350 mosm/kg and 65% at 400 mosm/kg. In the presence of 2 mmol/L glutamine, endothelial damage was completely prevented at 350 mosm/kg and significantly lessened at 400 mosm/kg compared with glutamine-free media. Confocal microscopy showed that most hypertonicity-treated cells exhibited the typical features of an apoptotic death and confirmed the osmoprotective effect of glutamine. CONCLUSIONS: These results indicate that the supplementation of hypertonic storage solutions with glutamine might exert a partial osmoprotective effect and suggest that the relationship between endothelial damage and tonicity of storage and cardioplegic solutions should be carefully investigated.


Asunto(s)
Endotelio Vascular/efectos de los fármacos , Glutamina/farmacología , Soluciones Hipertónicas/farmacología , Anciano , Apoptosis , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Medios de Cultivo , Endotelio Vascular/patología , Humanos , Técnicas In Vitro , Masculino , Microscopía Confocal , Persona de Mediana Edad , Presión Osmótica , Vena Safena/efectos de los fármacos
5.
J Card Surg ; 10(3): 227-35, 1995 May.
Artículo en Inglés | MEDLINE | ID: mdl-7626873

RESUMEN

The object of the study was to retrospectively evaluate protective and risk factors for receiving donor blood products and red cell transfusions after coronary and valve surgery performed with a hollow-fiber oxygenator and with multiple blood-saving techniques. During the period of January 1991 to June 1993, 1310 patients underwent primary coronary and valve surgery using a hollow-fiber oxygenator at our institution; the mean age of this population was 61 +/- 10 years; 977 patients were men (74.6%). Of these patients, 73.5% (963/1310) underwent coronary, 21.5% (281/1310) valve, and 5% (66/1310) combined surgery. Two hundred seventy-six (21.1%) needed donor blood product transfusions, while 153 (11.7%) patients underwent red cell transfusions. Significant risk factors for homologous blood product exposure after multivariate logistic regression analysis were, in order of importance: (1) postoperative blood loss (O.R. = 1.0009 per mL, p = 0.0000); (2) cardiopulmonary bypass (CPB) time (O.R. = 1.008 per min, p = 0.0001); (3) age at intervention (O.R. = 1.031 per calendar year, p = 0.0026); and (4) reoperation for bleeding (O.R. = 1.71, p = 0.0078). Protective factors were: (1) male gender (O.R. = 0.56, p = 0.0000); (2) preoperative withdrawal of autologous blood (O.R. = 0.66, p = 0.0018); and (3) a preoperative hematocrit greater than 34% (O.R. = 0.76, p = 0.0005).(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Transfusión de Componentes Sanguíneos , Transfusión de Sangre Autóloga , Vasos Coronarios/cirugía , Válvulas Cardíacas/cirugía , Oxigenadores de Membrana , Factores de Edad , Pérdida de Sangre Quirúrgica , Puente Cardiopulmonar , Transfusión de Eritrocitos , Femenino , Hematócrito , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Reoperación , Estudios Retrospectivos , Factores de Riesgo , Factores Sexuales , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA